Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 7.4M | 14.6M | 12.4M | 15.0M |
Selling general and admin | 3.0M | 1.9M | 3.7M | 3.0M |
Other operating expenses | — | — | — | — |
Operating income | -10.4M | -16.6M | -16.1M | -18.0M |
Non operating interest income | ||||
Income | 981.5K | 1.2M | 1.5M | 1.6M |
Expense | 483.5K | 470.9K | 479.3K | 477.6K |
Other income expense | — | — | — | — |
Pretax income | -9.9M | -15.8M | -15.1M | -16.8M |
Tax provision | — | — | — | — |
Net income | -9.9M | -15.8M | -15.1M | -16.8M |
Basic EPS | -0.2 | — | -0.3 | -0.3 |
Diluted EPS | -0.2 | — | -0.3 | -0.3 |
Basic average shares | 59.9M | — | 59.5M | 59.4M |
Diluted average shares | 59.9M | — | 59.5M | 59.4M |
EBITDA | -9.4M | -15.3M | -14.6M | -16.3M |
Net income from continuing op. | -9.9M | -15.8M | -15.1M | -16.8M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |